Durability of Bivalent Boosters against Omicron Subvariants
Durability of Bivalent Boosters against Omicron Subvariants
About this item
Full title
Durability of Bivalent Boosters against Omicron Subvariants
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2023-05, Vol.388 (19), p.1818-1820
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a trial of two bivalent Covid-19 boosters, effectiveness against severe infection resulting in hospitalization or death reached a level of 67.4% after 2 weeks and decreased to 38.4% after 20 weeks.
Alternative Titles
Full title
Durability of Bivalent Boosters against Omicron Subvariants
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10120009
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10120009
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2302462
